Xilong Scientific Co., Ltd. (SHE:002584)

Xilong Scientific Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	482.77	559.89	691.01	769.86	724.8	1,217
Trading Asset Securities	-	-	299.65	61.44	153	-
Cash & Short-Term Investments	482.77	559.89	990.66	831.3	877.8	1,217
Cash Growth	2.37%	-43.48%	19.17%	-5.30%	-27.89%	49.41%
Accounts Receivable	1,791	1,637	1,450	1,189	1,271	615.09
Other Receivables	84.51	83.99	278.16	520.58	31.22	86.3
Receivables	1,876	1,721	1,728	1,709	1,302	701.39
Inventory	723.55	561.66	508.2	454.42	713.34	395.26
Prepaid Expenses	-	0.03	0.67	0.2	0.08	0.32
Other Current Assets	454.56	486.84	460.11	704.38	401.34	589.52
Total Current Assets	3,537	3,329	3,688	3,699	3,295	2,904
Property, Plant & Equipment	854.87	845.7	691.6	489.93	513.13	564.61
Long-Term Investments	355.74	369.85	368.41	152.05	145.86	275.03
Goodwill	-	-	6.54	375.3	375.3	387.25
Other Intangible Assets	168.29	179.43	123.75	62.53	64.47	79.58
Long-Term Accounts Receivable	2.73	2.73	-	-	-	-
Long-Term Deferred Tax Assets	13.15	11.48	12.13	8.13	9.91	11.46
Long-Term Deferred Charges	7.02	9.29	35.43	17.41	11.47	7.96
Other Long-Term Assets	23.66	21.22	54.4	5.6	6.57	1.18
Total Assets	4,962	4,769	4,980	4,810	4,421	4,231
Accounts Payable	1,093	950.26	1,178	1,362	1,156	752.22
Accrued Expenses	10.43	46.87	53.04	61.17	52.97	38.65
Short-Term Debt	714.2	726.17	750.09	512.1	752.38	1,078
Current Portion of Long-Term Debt	156.58	155.83	66.46	114.27	-	30.61
Current Portion of Leases	-	9.43	1.72	7.11	-	-
Current Income Taxes Payable	45.98	3.73	8.28	3.65	31.83	9.86
Current Unearned Revenue	60.79	30.41	41.75	37.01	38.37	29.76
Other Current Liabilities	149.36	147.04	242.8	294.39	120.55	37.6
Total Current Liabilities	2,231	2,070	2,342	2,392	2,152	1,976
Long-Term Debt	372.4	319.09	280.03	94.98	174.91	217.43
Long-Term Leases	4.52	6.05	19.4	14.12	-	-
Long-Term Unearned Revenue	20.65	12.87	13.72	2.82	4.04	5.25
Long-Term Deferred Tax Liabilities	5.66	7.2	8.02	-	2.17	2.48
Other Long-Term Liabilities	-	-	-	-	-	30
Total Liabilities	2,634	2,415	2,663	2,504	2,333	2,231
Common Stock	585.22	585.22	585.22	585.22	585.22	585.22
Additional Paid-In Capital	682.38	682.38	682.38	682.38	669.34	676.53
Retained Earnings	1,010	1,032	999.15	911.06	722.66	640.93
Comprehensive Income & Other	44.27	47.9	43.83	46.91	39.38	39.45
Total Common Equity	2,322	2,348	2,311	2,226	2,017	1,942
Minority Interest	5.63	6.06	5.8	80.81	71.58	57.39
Shareholders' Equity	2,328	2,354	2,316	2,306	2,088	2,000
Total Liabilities & Equity	4,962	4,769	4,980	4,810	4,421	4,231
Total Debt	1,248	1,217	1,118	742.57	927.29	1,326
Net Cash (Debt)	-764.93	-656.68	-127.04	88.73	-49.49	-108.22
Net Cash Per Share	-1.39	-1.18	-0.21	0.17	-0.09	-0.20
Filing Date Shares Outstanding	585.22	585.22	585.22	585.22	585.22	585.22
Total Common Shares Outstanding	585.22	585.22	585.22	585.22	585.22	585.22
Working Capital	1,306	1,260	1,345	1,307	1,143	927.6
Book Value Per Share	3.97	4.01	3.95	3.80	3.45	3.32
Tangible Book Value	2,154	2,169	2,180	1,788	1,577	1,475
Tangible Book Value Per Share	3.68	3.71	3.73	3.05	2.69	2.52
Buildings	-	596.4	472.95	447.59	452.04	539.54
Machinery	-	241.28	205.2	176.27	197.38	216.83
Construction In Progress	-	207.89	185.53	12.77	41.36	9.74

Updated Oct 29, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.